Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
984 GBX | +0.31% | +0.94% | -8.76% |
Apr. 11 | UK Stocks Retreat as Hope for June BoE Rate Cut Dissipates | MT |
Apr. 11 | Proxy Advisers Raise Concerns Over Smith & Nephew's Pay Hike Proposal | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.76% | 10.65B | A- | ||
+13.16% | 128B | A- | ||
+3.60% | 8.82B | C | ||
+19.75% | 7.19B | C | ||
+22.28% | 4.99B | B+ | ||
+7.55% | 3.4B | C- | ||
-0.21% | 3.03B | B- | ||
-4.80% | 2.14B | - | - | |
-4.72% | 2B | - | ||
-22.91% | 1.79B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SN. Stock
- Ratings Smith & Nephew Plc